Latest News Archive

Please select Category, Year, and then Month to display items

Faculty of Economic and Management Sciences receives funding from European Union

06 April 2021 | Story Dr Nitha Ramnath | Photo Supplied

Dr Johan Coetzee_web read more — Dr Johan Coetzee, Senior Lecturer and researcher in the Department of Economics and Finance and the UFS Business School

Dr Johan Coetzee from the Faculty of Economic and Management Sciences at the University of the Free State (UFS) is championing a collaboration with the Salzburg University of Applied Sciences (SUAS) in Austria, resulting in the receipt of a considerable grant from the European Union.

In 2020, the decision was made to apply for Erasmus+ funding from the European Commission; after a successful grant, a formal inter-institutional agreement was signed in March 2021. The agreement is the culmination of a relationship between the Department of Economics and Finance at the UFS and the Department of Controlling and Finance at SUAS since 2008. More specifically, the relationship is built on the collaboration between the UFS’s Dr Coetzee and Prof Christine Mitter from the SUAS, who was recently appointed as a Research Fellow in Finance in the department.

“I am extremely proud of the formalisation of the relationship between the two universities. In late 2019, a delegation led by the Dean of Economic and Management Sciences, Prof Hendri Kroukamp, together with Prof Philippe Burger and myself visited Salzburg to formalise and iron out the expectations regarding future collaboration,” says Dr Coetzee.

“The Erasmus+ grant pays testament to not only on-boarding expertise from a foreign university with a strong niche in being practically relevant to the Austrian society, but also to affirming the relationship with like-minded scholars to provide students with a culturally rewarding university experience. This agreement brings together two departments with a history of working well together, and now it is a formal manifestation of years of mutually beneficial teaching and research efforts,” says Dr Coetzee.

“On the back of this agreement,” concludes Dr Coetzee, “our departments are also currently finalising a proposal to offer a consecutive degree exchange programme where prospective postgraduate students will obtain two master’s degrees in the broader field of finance and spend time on both campuses. We look forward to this becoming a reality in the not-too-distant future.”

In addition to their teaching and research collaboration, several additional academics from the Department of Economics and Finance are also involved in the teaching collaboration. Research projects have also been concluded in the past, with future projects in the pipeline.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept